Compare 10X Genomics Inc (TXG) vs Vanguard S&P 500 ETF (VOO) Price & Performance

10X Genomics IncTrade

Vanguard S&P 500 ETFTrade

Price performance (Past 24H)

Key statistics

10X Genomics Inc vs Vanguard S&P 500 ETF — how do they compare? 10X Genomics Inc trades at $47.2 (market cap $5.48B), while Vanguard S&P 500 ETF trades at $687.46. The key difference: 10X Genomics Inc is trading nearer its 52-week high, Vanguard S&P 500 ETF nearer its low. Which is the better fit depends on your goals.

	TXG	VOO
Market Cap	$5.48B	—
Sector	Health	Broad Market / Factor
52-Week High	$45.80	$698.29
52-Week Low	$11.34	$571.45
Enterprise Value	$5.02B	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

10X Genomics Inc

TXG trades at $47.20, up 7.91% on the day, with a bullish technical signal from moving averages. The company reported Q1 2026 revenue that beat estimates, and net losses have narrowed significantly from -$255M in 2023 to -$44M in 2025. Operating cash flow turned strongly positive at $136M in 2025. Recent developments include the acquisition of Proteintech Genomics and a collaboration with Cleveland Clinic on bladder cancer diagnostics.

The outlook is mixed; improving fundamentals and strategic expansions support growth, but persistent net losses and a high EV/EBITDA of 133.91 pose valuation risks. Analyst consensus is divided with a $39.14 price target below the current price, indicating caution despite a majority buy/hold ratings.

Vanguard S&P 500 ETF

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

TXG

New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

VOO

Buy rating maintained on US index assets despite AI sector volatility and bubble concerns.Seeking Alpha · 5 hours agoBullish DIA ETF underperforms S&P 500 ETFs due to higher fees and price-weighted index design.24/7 Wall Street · 3 days agoBearish SPY ETF charges higher fees than its cheaper sibling SPYM with identical S&P 500 exposure.24/7 Wall Street · 4 days agoBearish View details →

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

About Vanguard S&P 500 ETF

VOO is a foundational ETF that tracks the S&P 500 Index, providing exposure to 500 of the largest and most established companies in the United States. Renowned for its ultra-low expense ratio and tax efficiency, it serves as a core building block for long-term investors seeking to capture the total return of the U.S. large-cap market in a single, highly liquid vehicle.